{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:39:43Z","timestamp":1792625983355,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:00:00Z","timestamp":1792281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T00:00:00Z","timestamp":1792281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10549-026-08104-2","type":"journal-article","created":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:56:49Z","timestamp":1792346209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Awareness, need and utilization of breast cancer risk management resources in women with hereditary cancer susceptibility"],"prefix":"10.1007","volume":"220","author":[{"given":"Gerneiva","family":"Parkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hodan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6175-9470","authenticated-orcid":false,"given":"Allison W.","family":"Kurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,18]]},"reference":[{"issue":"5","key":"8104_CR1","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1056\/NEJMoa2005936","volume":"4","author":"C Hu","year":"2021","unstructured":"Hu C, Hart SN, Gnanaolivu R et al (2021) A Population-Based Study of Genes Previously Implicated in Breast Cancer. N Engl J Med Feb 4(5):440\u2013451. https:\/\/doi.org\/10.1056\/NEJMoa2005936","journal-title":"N Engl J Med Feb"},{"issue":"5","key":"8104_CR2","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1913948","volume":"4","author":"C Breast Cancer Association","year":"2021","unstructured":"Breast Cancer Association C, Dorling L, Carvalho S et al (2021) Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. N Engl J Med Feb 4(5):428\u2013439. https:\/\/doi.org\/10.1056\/NEJMoa1913948","journal-title":"N Engl J Med Feb"},{"issue":"6","key":"8104_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1706450","volume":"10","author":"M Robson","year":"2017","unstructured":"Robson M, Im SA, Senkus E et al (2017) Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. N Engl J Med Aug 10(6):523\u2013533. https:\/\/doi.org\/10.1056\/NEJMoa1706450","journal-title":"N Engl J Med"},{"key":"8104_CR4","unstructured":"Litton JRH, Ettl J, Hurvitz S, Goncalves A, Lee KH et al (2017) EMBRACA: A phase III trial comparing talazoparib, an oral PARP inhibitor, to physician\u2019s choice of therapy in patients with advanced germline BRCA-mutated breast cancer. presented at: San Antonio Breast Cancer Symposium; Presented December 8, 2017; San Antonio, Texas"},{"key":"8104_CR5","doi-asserted-by":"publisher","unstructured":"Domchek SM (2019, Jan 1) Risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers: a complex discussion. JAMA 321(1):27. https:\/\/doi.org\/10.1001\/jama.2018.18942","DOI":"10.1001\/jama.2018.18942"},{"issue":"2","key":"8104_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.6004\/jnccn.2026.0007","volume":"24","author":"HH Cheng","year":"2026","unstructured":"Cheng HH, Giri VN, Goggins M et al (2026) NCCN Guidelines(R) Insights: Genetic\/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate, Version 2.2026. J Natl Compr Canc Netw Feb 24(2):2\u201310. https:\/\/doi.org\/10.6004\/jnccn.2026.0007","journal-title":"J Natl Compr Canc Netw Feb"},{"issue":"5","key":"8104_CR7","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1200\/JCO.23.02225","volume":"10","author":"I Bedrosian","year":"2024","unstructured":"Bedrosian I, Somerfield MR, Achatz MI et al (2024) Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline. J Clin Oncol Feb 10(5):584\u2013604. https:\/\/doi.org\/10.1200\/JCO.23.02225","journal-title":"J Clin Oncol Feb"},{"issue":"10","key":"8104_CR8","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1245\/s10434-019-07549-8","volume":"26","author":"ER Manahan","year":"2019","unstructured":"Manahan ER, Kuerer HM, Sebastian M et al (2019) Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons. Ann Surg Oncol Oct 26(10):3025\u20133031. https:\/\/doi.org\/10.1245\/s10434-019-07549-8","journal-title":"Ann Surg Oncol Oct"},{"issue":"3","key":"8104_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10549-021-06478-z","volume":"191","author":"S Reid","year":"2022","unstructured":"Reid S, Spalluto LB, Lang K, Weidner A, Pal T (2022 Feb) An overview of genetic services delivery for hereditary breast cancer. Breast Cancer Res Treat 191(3):491\u2013500. https:\/\/doi.org\/10.1007\/s10549-021-06478-z","journal-title":"Breast Cancer Res Treat Feb"},{"key":"8104_CR10","doi-asserted-by":"publisher","first-page":"298745","DOI":"10.1155\/2012\/298745","volume":"2012","author":"B Anderson","year":"2012","unstructured":"Anderson B, McLosky J, Wasilevich E, Lyon-Callo S, Duquette D, Copeland G (2012) Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors. J Cancer Epidemiol 298745. https:\/\/doi.org\/10.1155\/2012\/298745","journal-title":"J Cancer Epidemiol"},{"issue":"7","key":"8104_CR11","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/pon.3187","volume":"22","author":"KM Sussner","year":"2013","unstructured":"Sussner KM, Jandorf L, Thompson HS, Valdimarsdottir HB (2013) Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City. Psychooncology Jul 22(7):1594\u20131604. https:\/\/doi.org\/10.1002\/pon.3187","journal-title":"Psychooncology Jul"},{"issue":"2","key":"8104_CR12","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1200\/JCO.2009.22.7991","volume":"10","author":"AW Kurian","year":"2010","unstructured":"Kurian AW, Sigal BM, Plevritis SK (2010) Survival analysis of cancer risk reduction strategies for BRCA1\/2 mutation carriers. J Clin Oncol Jan 10(2):222\u2013231. https:\/\/doi.org\/10.1200\/JCO.2009.22.7991","journal-title":"J Clin Oncol Jan"},{"issue":"9","key":"8104_CR13","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1001\/jamaoncol.2025.2203","volume":"24","author":"X Wei","year":"2025","unstructured":"Wei X, Mansour L, Oxley S et al (2025) Defining Lifetime Risk Thresholds for Breast Cancer Surgical Prevention. JAMA Oncol Jul 24(9):1072\u20131082. https:\/\/doi.org\/10.1001\/jamaoncol.2025.2203","journal-title":"JAMA Oncol Jul"},{"issue":"20","key":"8104_CR14","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1001\/jama.295.20.2374","volume":"24","author":"SK Plevritis","year":"2006","unstructured":"Plevritis SK, Kurian AW, Sigal BM et al (2006) Cost-effectiveness of screening BRCA1\/2 mutation carriers with breast magnetic resonance imaging. JAMA May 24(20):2374\u20132384. https:\/\/doi.org\/10.1001\/jama.295.20.2374","journal-title":"JAMA May"},{"issue":"1","key":"8104_CR15","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1200\/JOP.19.00221","volume":"16","author":"D Scott","year":"2020","unstructured":"Scott D, Friedman S, Telli ML, Kurian AW (2020) Decision Making About Genetic Testing Among Women With a Personal and Family History of Breast Cancer. JCO Oncol Pract Jan 16(1):e37\u2013e55. https:\/\/doi.org\/10.1200\/JOP.19.00221","journal-title":"JCO Oncol Pract Jan"},{"issue":"1","key":"8104_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cgh.2022.10.025","volume":"21","author":"NJ Rodriguez","year":"2023","unstructured":"Rodriguez NJ, Ricker C, Stoffel EM, Syngal S (2023) Barriers and Facilitators to Genetic Education, Risk Assessment, and Testing: Considerations on Advancing Equitable Genetics Care. Clin Gastroenterol Hepatol Jan 21(1):3\u20137. https:\/\/doi.org\/10.1016\/j.cgh.2022.10.025","journal-title":"Clin Gastroenterol Hepatol Jan"},{"key":"8104_CR17","doi-asserted-by":"publisher","first-page":"106735","DOI":"10.1016\/j.cct.2022.106735","volume":"116","author":"AK Reed","year":"2022","unstructured":"Reed AK, Kohn MJ, Stayman S et al (2022) Patient navigation for hereditary colorectal cancer: Design of a randomized controlled trial to determine the effectiveness of pathways to genetic counseling. Contemp Clin Trials May 116:106735. https:\/\/doi.org\/10.1016\/j.cct.2022.106735","journal-title":"Contemp Clin Trials May"},{"key":"8104_CR18","doi-asserted-by":"publisher","unstructured":"Mittendorf KF, Knerr S, Kauffman TL et al (2021) Systemic barriers to risk-reducing interventions for hereditary cancer syndromes: implications for health care inequities. JCO Precis Oncol 5. https:\/\/doi.org\/10.1200\/PO.21.00233","DOI":"10.1200\/PO.21.00233"},{"issue":"3","key":"8104_CR19","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10549-019-05345-2","volume":"177","author":"BAM Heemskerk-Gerritsen","year":"2019","unstructured":"Heemskerk-Gerritsen BAM, Jager A, Koppert LB et al (2019) Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat Oct 177(3):723\u2013733. https:\/\/doi.org\/10.1007\/s10549-019-05345-2","journal-title":"Breast Cancer Res Treat Oct"},{"issue":"10","key":"8104_CR20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1200\/JCO-25-00834","volume":"44","author":"A Gandhi","year":"2026","unstructured":"Gandhi A, Howell SJ, Harkness EF et al (2026) Survival Outcomes With or Without Risk-Reducing Mastectomy in. J Clin Oncol Apr 44(10):874\u2013882. https:\/\/doi.org\/10.1200\/JCO-25-00834","journal-title":"J Clin Oncol Apr"},{"issue":"3","key":"8104_CR21","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1001\/jamasurg.2025.5929","volume":"01","author":"C O\u2019Reilly","year":"2026","unstructured":"O\u2019Reilly C, McGarry JL, Zaborowski AM et al (2026) Risk-Reducing Bilateral Mastectomy and Mortality in Carriers of BRCA1 and BRCA2 Variants: A Systematic Review and Meta-Analysis. JAMA Surg Mar 01(3):260\u2013267. https:\/\/doi.org\/10.1001\/jamasurg.2025.5929","journal-title":"JAMA Surg Mar"},{"issue":"23","key":"8104_CR22","doi-asserted-by":"publisher","first-page":"e70357","DOI":"10.1002\/cam4.70357","volume":"13","author":"C Benedict","year":"2024","unstructured":"Benedict C, Nouriani B, Neri E et al (2024) Emotional Reactivity and Regulation Relate to Surgical Treatment Decision Making Among Newly Diagnosed Women With Breast Cancer. Cancer Med Dec 13(23):e70357. https:\/\/doi.org\/10.1002\/cam4.70357","journal-title":"Cancer Med Dec"},{"issue":"11","key":"8104_CR23","doi-asserted-by":"publisher","first-page":"12837","DOI":"10.1002\/cam4.5963","volume":"12","author":"JX Zhang","year":"2023","unstructured":"Zhang JX, Kurian AW, Jo B et al (2023) Emotion regulation and choice of bilateral mastectomy for the treatment of unilateral breast cancer. Cancer Med Jun 12(11):12837\u201312846. https:\/\/doi.org\/10.1002\/cam4.5963","journal-title":"Cancer Med Jun"},{"issue":"6","key":"8104_CR24","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s10434-999-0542-1","volume":"6","author":"LL Montgomery","year":"1999","unstructured":"Montgomery LL, Tran KN, Heelan MC et al (1999) Issues of regret in women with contralateral prophylactic mastectomies. Ann Surg Oncol Sep 6(6):546\u2013552. https:\/\/doi.org\/10.1007\/s10434-999-0542-1","journal-title":"Ann Surg Oncol Sep"},{"key":"8104_CR25","doi-asserted-by":"publisher","unstructured":"Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA (2007) Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol Nov 20(33):5203\u20135209 https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2007.12.3141 [pii] https:\/\/doi.org\/10.1200\/JCO.2007.12.3141","DOI":"10.1200\/JCO.2007.12.3141"},{"key":"8104_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.15585\/mmwr.mm7002a1","volume":"70","author":"SATT Sabatino","year":"2021","unstructured":"Sabatino SA, Thompson TD, White MC (2021) Cancer Screening Test Receipt \u2014 United States, 2018. MMWR Morb Mortal Wkly Rep 70:29\u201335. https:\/\/doi.org\/10.15585\/mmwr.mm7002a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"8104_CR27","doi-asserted-by":"publisher","first-page":"e1926","DOI":"10.1002\/jgc4.1926","volume":"34","author":"S Austin","year":"2025","unstructured":"Austin S, Hanson EN, Delacroix E et al (2025) Impact of barriers and motivators on intention and confidence to undergo hereditary cancer genetic testing. J Genet Couns Feb 34(1):e1926. https:\/\/doi.org\/10.1002\/jgc4.1926","journal-title":"J Genet Couns Feb"},{"key":"8104_CR28","doi-asserted-by":"publisher","unstructured":"Kurian AW, Lichtensztajn DY, Keegan TH, Nelson DO, Clarke CA, Gomez SL (2014, Sep 3) Use of and mortality after bilateral mastectomy compared with other surgical treatments for breast cancer in California, 1998\u20132011. JAMA 312(9):902\u2009\u2013\u200914. https:\/\/doi.org\/10.1001\/jama.2014.10707","DOI":"10.1001\/jama.2014.10707"},{"issue":"12","key":"8104_CR29","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/jnci\/djz091","volume":"1","author":"SL Gomez","year":"2019","unstructured":"Gomez SL, Yao S, Kushi LH, Kurian AW (2019) Is Breast Cancer in Asian and Asian American Women a Different Disease? J Natl Cancer Inst Dec 1(12):1243\u20131244. https:\/\/doi.org\/10.1093\/jnci\/djz091","journal-title":"J Natl Cancer Inst Dec"},{"issue":"14","key":"8104_CR30","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1200\/JCO.2014.58.5885","volume":"10","author":"R Jagsi","year":"2015","unstructured":"Jagsi R, Griffith KA, Kurian AW et al (2015) Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer. J Clin Oncol May 10(14):1584\u20131591. https:\/\/doi.org\/10.1200\/JCO.2014.58.5885","journal-title":"J Clin Oncol May"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08104-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-08104-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-026-08104-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:06:08Z","timestamp":1792623968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-026-08104-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,18]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["8104"],"URL":"https:\/\/doi.org\/10.1007\/s10549-026-08104-2","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,18]]},"assertion":[{"value":"5 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Survey respondent flow into the analytic cohort.","order":1,"name":"Ethics","label":"Supplemental figure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"5"}}